Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma

Oncology Letters

Volumn 5, Issue 1, 2012, Pages 261-266

  Wu, Xiao Hong ^a   Chen, Su Ping ^b   Mao, Jian Ying ^a   Ji, Xue Xian ^a   Yao, Hong Tian ^a   Zhou, Shui Hong ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Glucose transporter 1; Hypoxia inducible factor 1a; Laryngeal carcinoma; Prognosis

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX SQUAMOUS CELL CARCINOMA; LEUKOPLAKIA; LYMPH NODE METASTASIS; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

EID: 84869018656     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.941     Document Type: Article

References (29)

1. Yasuda M, Miyazawa M, Fujita M, et al: Expression of hypoxia inducible factor-1α (HIF-1α) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character. Oncol Rep 19: 111-116, 2008.
2. Havelund BM, Sørensen FB, Lindebjerg J, Spindler KL and Jakobsen A: Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer. Anticancer Res 31: 1559-1565, 2011.
3. Gu J, Yamamoto H, Fukunaga H, et al: Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci 51: 198-205, 2006.
4. Merrall NW, Plevin R and Gould GW: Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell Signal 5: 667-675, 1993.
5. Zhou S, Wang S, Wu Q, Fan J and Wang Q: Expression of glucose transporter-1 and-3 in the head and neck carcinoma-the correlation of the expression with the biological behaviors. ORL J Otorhinolaryngol Relat Spec 70: 189-194, 2008.
6. Eckert AW, Lautner MH, Taubert H, Schubert J and Bilkenroth U: Expression of Glut-1 is a prognostic marker for oral squamous cell carcinoma patients. Oncol Rep 20: 1381-1385, 2008.
7. Deron P, Vermeersch H, Mees G, Vangestel C, Pauwels P and Vande Wiele C: Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma. Histol Histopathol 26: 1165-1172, 2011.
8. Nakajo M, Nakajo M, Tani A, et al: Clinical significance of primary lesion FDG uptake for choice between oesophagectomy and endoscopic submucosal dissection for resectable oesophageal squamous cell carcinomas. Eur Radiol 21: 2396-2407, 2011.
9. Kondo Y, Yoshikawa K, Omura Y, et al: Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma. Oncol Rep 25: 1227-1233, 2011.
10. Deron P, Vangestel C, Goethals I, et al: FDG uptake in primary squamous cell carcinoma of the head and neck. The relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis. Nuklearmedizin 50: 15-21, 2011.
11. Ayala FR, Rocha RM, Carvalho KC, et al: GLUT1 and GLUT3 as potential prognostic markers for oral squamous cell carcinoma. Molecules 15: 2374-2387, 2010.
12. Pez F, Dayan F, Durivault J, et al: The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Cancer Res 71: 1647-1657, 2011.
13. Eckert AW, Lautner MH, Schütze A, Taubert H, Schubert J and Bilkenroth U: Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients. Histopathology 58: 1136-1147, 2011.
14. Ogane N, Yasuda M, Shimizu M, et al: Clinicopathological implications of expressions of hypoxia-related molecules in esophageal superficial squamous cell carcinoma. Ann Diagn Pathol 14: 23-29, 2010.
15. Sulkowska M, Wincewicz A, Sulkowski S, Koda M and Kanczuga-Koda L: Relations of TGF-beta1 with HIF-1alpha, GLUT-1 and longer survival of colorectal cancer patients. Pathology 41: 254-260, 2009.
16. Iida T, Yasuda M, Miyazawa M, et al: Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1α/GLUT-1 expression. Arch Gynecol Obstet 277: 539-546, 2008.
17. Lidgren A, Bergh A, Grankvist K, Rasmuson T and Ljungberg B: Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha. BJU Int 101: 480-484, 2008.
18. Palit V, Phillips RM, Puri R, Shah T and Bibby MC: Expression of HIF-1α and Glut-1 in human bladder cancer. Oncol Rep 14: 909-913, 2005.
19. Koukourakis MI, Giatromanolaki A, Harris AL and Sivridis E: Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 66: 632-637, 2006.
20. Wincewicz A, Sulkowska M, Koda M and Sulkowski S: Clinicopathological significance and linkage of the distribution of HIF-1α and GLUT-1 in human primary colorectal cancer. Pathol Oncol Res 13: 15-20, 2007.
21. Schrijvers ML, van der Laan BF, de Bock GH, et al: Overexpression of intrinsic hypoxia markers HIF1α and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 72: 161-169, 2008.
22. Wu XH, Lu YF, Hu XD, et al: Expression of hypoxia inducible factor-1α and its significance in laryngeal carcinoma. J Int Med Res 38: 2040-2046, 2010.
23. Yu L, Liu Y and Cui Y: Expression of hypoxia inducible factor-1alpha and its relationship to apoptosis and proliferation in human laryngeal squamous cell carcinoma. J Huazhong Univ Sci Technolog Med Sci 24: 636-638, 2004.
24. Luo XM, Zhou SH and Fan J: Glucose transporter-1 as a new therapeutic target in laryngeal carcinoma. J Int Med Res 38: 1885-1892, 2010.
25. Zhou SH, Fan J, Chen XM, Cheng KJ and Wang SQ: Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter-1. Head Neck 31: 1624-1633, 2009.
26. Weljie AM and Jirik FR: Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect. Int J Biochem Cell Biol 43: 981-989, 2011.
27. Wan J, Chai H, Yu Z, et al: HIF-1α effects on angiogenic potential in human small cell lung carcinoma. J Exp Clin Cancer Res 30: 77, 2011.
28. Cabanillas R, Rodrigo JP, Secades P, et al: The relation between hypoxia-inducible factor (HIF)-1α expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer. J Surg Oncol 99: 373-378, 2009.
29. Wildeman MA, Gibcus JH, Hauptmann M, et al: Radiotherapy in laryngeal carcinoma: can a panel of 13 markers predict response? Laryngoscope 119: 316-322, 2009.